CS
IDNA icon

Credit Suisse’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Credit Suisse’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,392
Closed -$35K – 3485
2022
Q4 		$35K Hold
1,392
– – ﹤0.01% 3433
2022
Q3 		$37K Hold
1,392
– – ﹤0.01% 3558
2022
Q2 		$40K Buy
+1,392
New +$41.5K ﹤0.01% 3651

Other funds holding IDNA

WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
WAP
Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Credit Suisse's IDNA Position: Q1 2023 in Review

Credit Suisse sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q1 2023, closing a stake of 1,392 shares — an estimated $35K sold.

Credit Suisse first reported a position in IDNA in Q2 2022 and held it in 3 quarters. The position peaked at $40K in Q2 2022. 75 funds tracked by Wall St. Rank hold IDNA as of Q1 2023.

  • Credit Suisse reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q1 2023 after selling out during the quarter.
  • Credit Suisse sold 1,392 iShares Genomics Immunology and Healthcare ETF shares in Q1 2023, an estimated $35K.
  • Credit Suisse first reported a position in iShares Genomics Immunology and Healthcare ETF in Q2 2022 and held it in 3 quarters.
  • Credit Suisse's iShares Genomics Immunology and Healthcare ETF position peaked at $40K in Q2 2022.
  • 75 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2023.

Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.